Business
March 13 Policy Watch: FDA streamlines its process for approving biosimilar drugs
March 13 Policy Watch: FDA streamlines its process for approving biosimilar drugs In another development, 25 states have petitioned to join a lawsuit and defend the EPA’s decision to rescind the clim...
